Idenix Pharmaceuticals Inc (NASDAQ:IDIX)

24.33
Data as of Jul 25
 0.00 / 0.00%
Today’s Change
2.93
Today|||52-Week Range
24.37
+306.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.7B

Company Description

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.

Contact Information

Idenix Pharmaceuticals, Inc.
320 Bent Street
Cambridge Massachusetts 02141
P:(617) 995-9800
Investor Relations:
(617) 995-9807

Employees

Shareholders

Other institutional59.35%
Individual stakeholders31.53%
Mutual fund holders19.87%

Top Executives

Ronald C. RenaudPresident, Chief Executive Officer & Director
Daniella BeckmanChief Financial Officer, Treasurer & Senior VP
Douglas L. MayersChief Medical Officer & EVP-Clinical Development
Jacques DumasChief Scientific Officer & Executive VP
Maria D. StahlSecretary, Senior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.